Johnson & Johnson said on Monday it would buy Pfizer Inc.’s consumer healthcare business for $16.6 billion in cash to increase its lead in the market for non-prescription health products.
*For more on this story,
read the full Reuters article.
Johnson & Johnson said on Monday it would buy Pfizer Inc.’s consumer healthcare business for $16.6 billion in cash to increase its lead in the market for non-prescription health products.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99